Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spigelman

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Homo : Internationale Zeitschrift Fur Die Vergleichende Forschung Am Menschen|June 7, 2015
Evidence of probable tuberculosis in Lithuanian mummiesD Piombino-Mascali, R Jankauskas, A Tamošiūnas, et al.
Oncology|January 1, 1989
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusionH W Bruckner, J Kalman, M Spigelman, et al.
The Journal of Infectious Diseases|January 10, 2025
Estimating the Early Transmission Inhibition of new treatment regimens for drug-resistant tuberculosisA Stoltz, R R Nathavitharana, E de Kock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the presentB M Rothschild, L D Martin, G Lev, et al.
Cancer Investigation|January 1, 1996
Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patientsW Kreis, K Chan, D R Budman, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2011
Towards new business models for R&D for novel antibioticsA D So, N Gupta, S K Brahmachari, et al.
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohortsS Oelofse, A Esmail, A H Diacon, et al.
BMC Medicine|March 30, 2018
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB studyConor Duncan Tweed, Genevieve Helen Wills, Angela M Crook, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 25, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBC D Tweed, G H Wills, A M Crook, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Homo : Internationale Zeitschrift Fur Die Vergleichende Forschung Am Menschen|June 7, 2015
Evidence of probable tuberculosis in Lithuanian mummiesD Piombino-Mascali, R Jankauskas, A Tamošiūnas, et al.
Oncology|January 1, 1989
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusionH W Bruckner, J Kalman, M Spigelman, et al.
The Journal of Infectious Diseases|January 10, 2025
Estimating the Early Transmission Inhibition of new treatment regimens for drug-resistant tuberculosisA Stoltz, R R Nathavitharana, E de Kock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the presentB M Rothschild, L D Martin, G Lev, et al.
Cancer Investigation|January 1, 1996
Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patientsW Kreis, K Chan, D R Budman, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2011
Towards new business models for R&D for novel antibioticsA D So, N Gupta, S K Brahmachari, et al.
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohortsS Oelofse, A Esmail, A H Diacon, et al.
BMC Medicine|March 30, 2018
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB studyConor Duncan Tweed, Genevieve Helen Wills, Angela M Crook, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 25, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBC D Tweed, G H Wills, A M Crook, et al.
Pageof 4